Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Cook

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Plos One|September 13, 2011
Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activityErica B Wilson, Jehan J El-Jawhari, Abbie L Neilson, et al.
The Biochemical Journal|August 14, 2010
Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killingGina B Scott, Paul A Bowles, Erica B Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHTTim D Holmes, Erica B Wilson, Emma V I Black, et al.
Medical Image Analysis|February 7, 2024
Immune subtyping of melanoma whole slide images using multiple instance learningLucy Godson, Navid Alemi, Jérémie Nsengimana, et al.
Immunology|February 14, 2022
Oncolytic virus treatment differentially affects the CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cell subsets in vivo and regulates a spectrum of human NK cell activityMichelle Wantoch, Erica B Wilson, Alastair P Droop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Proteolytic activation of the cytotoxic phenotype during human NK cell developmentJosephine L Meade, Erica B Wilson, Tim D Holmes, et al.
International Journal of Cancer|November 2, 2012
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cellsRobert A Adair, Karen J Scott, Sheila Fraser, et al.
The Journal of Investigative Dermatology|April 7, 2024
Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary MelanomaJuliette Randerson-Moor, John Davies, Mark Harland, et al.
Journal of Autoimmunity|January 7, 2014
TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytesSinisa Savic, Lylia Ouboussad, Laura J Dickie, et al.
Cancer Research|September 19, 2007
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cellsYasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Plos One|September 13, 2011
Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activityErica B Wilson, Jehan J El-Jawhari, Abbie L Neilson, et al.
The Biochemical Journal|August 14, 2010
Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killingGina B Scott, Paul A Bowles, Erica B Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHTTim D Holmes, Erica B Wilson, Emma V I Black, et al.
Medical Image Analysis|February 7, 2024
Immune subtyping of melanoma whole slide images using multiple instance learningLucy Godson, Navid Alemi, Jérémie Nsengimana, et al.
Immunology|February 14, 2022
Oncolytic virus treatment differentially affects the CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cell subsets in vivo and regulates a spectrum of human NK cell activityMichelle Wantoch, Erica B Wilson, Alastair P Droop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Proteolytic activation of the cytotoxic phenotype during human NK cell developmentJosephine L Meade, Erica B Wilson, Tim D Holmes, et al.
International Journal of Cancer|November 2, 2012
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cellsRobert A Adair, Karen J Scott, Sheila Fraser, et al.
The Journal of Investigative Dermatology|April 7, 2024
Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary MelanomaJuliette Randerson-Moor, John Davies, Mark Harland, et al.
Journal of Autoimmunity|January 7, 2014
TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytesSinisa Savic, Lylia Ouboussad, Laura J Dickie, et al.
Cancer Research|September 19, 2007
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cellsYasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, et al.
Pageof 5